Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Redmond

Showing results (151-160 of 205) with videos related to

Pageof 21
Sort By:
Contemporary Clinical Trials Communications|February 27, 2023
eDECIDE a web-based problem-solving interventions for diabetes self-management: Protocol for a pilot clinical trialMichelle L Redmond, Nicole Nollen, Hayrettin Okut, et al.
Journal of the American Chemical Society|May 9, 2008
Crystal structure and the paraelectric-to-ferroelectric phase transition of nanoscale BaTiO3Millicent B Smith, Katharine Page, Theo Siegrist, et al.
International Journal for Parasitology|December 8, 2007
Stage-specific gene expression in Teladorsagia circumcincta (Nematoda: Strongylida) infective larvae and early parasitic stagesAlasdair J Nisbet, Diane L Redmond, Jacqui B Matthews, et al.
The Prostate|August 22, 2000
Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progressionH J Dawkins, L N Sellner, G R Turbett, et al.
The Laryngoscope|March 29, 2013
Tympanic membrane repair using silk fibroin and acellular collagen scaffoldsYi Shen, Sharon L Redmond, Bing Mei Teh, et al.
The Analyst|August 23, 2022
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeuticsNoriko Iwamoto, Yoshinobu Koguchi, Kotoko Yokoyama, et al.
Journal for Immunotherapy of Cancer|October 8, 2021
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumabYoshinobu Koguchi, Noriko Iwamoto, Takashi Shimada, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2017
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscapeLeisha A Emens, Paolo A Ascierto, Phillip K Darcy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance allelesXavier Martinez, Huub T C Kreuwel, William L Redmond, et al.
Scientific Reports|February 12, 2026
Bacterial colonization of tumors drives immune activation and checkpoint blockade efficacyAnnah S Rolig, Tahereh Ziglari, Grace Helen McGee, et al.
Pageof 21

Showing results (151-160 of 205) with videos related to

Sort By:
Pageof 21
Contemporary Clinical Trials Communications|February 27, 2023
eDECIDE a web-based problem-solving interventions for diabetes self-management: Protocol for a pilot clinical trialMichelle L Redmond, Nicole Nollen, Hayrettin Okut, et al.
Journal of the American Chemical Society|May 9, 2008
Crystal structure and the paraelectric-to-ferroelectric phase transition of nanoscale BaTiO3Millicent B Smith, Katharine Page, Theo Siegrist, et al.
International Journal for Parasitology|December 8, 2007
Stage-specific gene expression in Teladorsagia circumcincta (Nematoda: Strongylida) infective larvae and early parasitic stagesAlasdair J Nisbet, Diane L Redmond, Jacqui B Matthews, et al.
The Prostate|August 22, 2000
Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progressionH J Dawkins, L N Sellner, G R Turbett, et al.
The Laryngoscope|March 29, 2013
Tympanic membrane repair using silk fibroin and acellular collagen scaffoldsYi Shen, Sharon L Redmond, Bing Mei Teh, et al.
The Analyst|August 23, 2022
A rapid and universal liquid chromatograph-mass spectrometry-based platform, refmAb-Q nSMOL, for monitoring monoclonal antibody therapeuticsNoriko Iwamoto, Yoshinobu Koguchi, Kotoko Yokoyama, et al.
Journal for Immunotherapy of Cancer|October 8, 2021
Trough levels of ipilimumab in serum as a potential biomarker of clinical outcomes for patients with advanced melanoma after treatment with ipilimumabYoshinobu Koguchi, Noriko Iwamoto, Takashi Shimada, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2017
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscapeLeisha A Emens, Paolo A Ascierto, Phillip K Darcy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance allelesXavier Martinez, Huub T C Kreuwel, William L Redmond, et al.
Scientific Reports|February 12, 2026
Bacterial colonization of tumors drives immune activation and checkpoint blockade efficacyAnnah S Rolig, Tahereh Ziglari, Grace Helen McGee, et al.
Pageof 21